- Home
- ARWR vs CAAP Comparison
ARWR vs CAAP Comparison
Compare ARWR & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CAAP
- Stock Information
- Founded
- ARWR 2003
- CAAP 1998
- Country
- ARWR United States
- CAAP Luxembourg
- Employees
- ARWR N/A
- CAAP N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CAAP Aerospace
- Sector
- ARWR Health Care
- CAAP Consumer Discretionary
- Exchange
- ARWR Nasdaq
- CAAP Nasdaq
- Market Cap
- ARWR 2.5B
- CAAP 2.4B
- IPO Year
- ARWR 1993
- CAAP 2018
- Fundamental
- Price
- ARWR $18.57
- CAAP $18.82
- Analyst Decision
- ARWR Buy
- CAAP Strong Buy
- Analyst Count
- ARWR 11
- CAAP 1
- Target Price
- ARWR $45.33
- CAAP $21.50
- AVG Volume (30 Days)
- ARWR 997.3K
- CAAP 124.8K
- Earning Date
- ARWR 11-26-2024
- CAAP 11-26-2024
- Dividend Yield
- ARWR N/A
- CAAP N/A
- EPS Growth
- ARWR N/A
- CAAP 114.63
- EPS
- ARWR N/A
- CAAP 2.22
- Revenue
- ARWR $19,648,000.00
- CAAP $1,471,077,000.00
- Revenue This Year
- ARWR N/A
- CAAP $27.07
- Revenue Next Year
- ARWR $100.95
- CAAP $19.62
- P/E Ratio
- ARWR N/A
- CAAP $8.46
- Revenue Growth
- ARWR N/A
- CAAP N/A
- 52 Week Low
- ARWR $17.05
- CAAP $11.40
- 52 Week High
- ARWR $39.83
- CAAP $19.95
- Technical
- Relative Strength Index (RSI)
- ARWR 35.87
- CAAP 53.06
- Support Level
- ARWR $21.20
- CAAP $18.69
- Resistance Level
- ARWR $22.03
- CAAP $19.71
- Average True Range (ATR)
- ARWR 0.87
- CAAP 0.61
- MACD
- ARWR -0.04
- CAAP -0.03
- Stochastic Oscillator
- ARWR 0.76
- CAAP 29.81
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.